Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 64980-211

10 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 64980-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural-formula (Structural Formula)

Structural-formula (Structural Formula)
Chemical structure of Oxybutynin Chloride, showing the molecular arrangement of atoms including aromatic, ester, alkyne, amine, and hydrochloride groups.*
FDA Label Image

Fig-1 (Fig 1)

Fig-1 (Fig 1)
A line graph showing mean plasma R-oxybutynin concentration (ng/mL) over 24 hours comparing oxybutynin chloride extended-release tablets 10 mg once daily and oxybutynin 5 mg three times daily. Concentration levels are plotted on the y-axis, and time in hours is on the x-axis, with error bars indicating variability around each data point.*
FDA Label Image

Fig-2 (Fig 2)

Fig-2 (Fig 2)
A line graph showing mean R-Oxybutynin plasma concentration (ng/mL) over time (hours). The graph ranges from 0 to 24 hours on the x-axis and 0 to 2.0 ng/mL on the y-axis, with data points including error bars indicating variability around each mean concentration measurement.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A scientific chart comparing Oxybutynin Chloride extended-release tablets to placebo. The chart displays horizontal error bars representing the range of values for each group, with a central marker indicating the average or point estimate. The x-axis ranges approximately from -40 to 40, showing comparative data without specific numeric labels or further context provided.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A horizontal error bar chart comparing 'Oxybutynin chloride extended-release tablets' and 'oxybutynin'. The x-axis ranges approximately from -40 to 40, with labels at -40, -20, 0, 20, and 40. Each label has horizontal error bars extending on either side, with the oxybutynin label centered near -20. No specific values or units are shown.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
A forest plot figure presenting the effect estimates and confidence intervals for oxybutynin chloride extended-release tablets and oxybutynin. The plot shows a comparison of values ranging from -40 to 40 on the x-axis, illustrating statistical data for these substances.*
FDA Label Image
Rising-logo (Rising Logo)
FDA Label Image

5mg-100ct-label (5mg 100ct Label)

5mg-100ct-label (5mg 100ct Label)
Label for Oxybutynin Chloride Extended-Release Tablets USP 5 mg by Rising Pharmaceuticals, containing 100 tablets. Includes storage instructions, manufacturer and distributor details, barcode, and notes that the product is Rx only.*
FDA Label Image

10mg-100ct-label (10mg 100ct Label)

10mg-100ct-label (10mg 100ct Label)
Oxybutynin Chloride Extended-Release Tablets USP 10 mg in a 100-tablet package. The label shows the brand Rising Pharmaceuticals, indicates 'Rx only', and includes storage instructions and manufacturer details for Rising Pharma Holdings, Inc. The tablet strength is prominently displayed in red.*
FDA Label Image

15mg-100ct-label (15mg 100ct Label)

15mg-100ct-label (15mg 100ct Label)
Label for Oxybutynin Chloride Extended-Release Tablets USP 15 mg, oral tablets, containing 100 count. The label includes the brand Rising Pharmaceuticals, a barcode, and notes it is Rx only. The label states the tablet contains 15 mg oxybutynin chloride USP in a controlled-release formulation, with storage instructions and manufacturer information from Unique Pharmaceutical Laboratories Ltd. and distributor Rising Pharma Holdings, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.